Oncogenic MORC2 in cancer development and beyond

Shan Zhang; Ayao Guo; Huan Wang; Jia Liu; Chenshuang Dong; Junyi Ren; Guiling Wang

doi:10.1016/j.gendis.2023.05.010

您当前的位置：

首页 >

文章列表页 >

Oncogenic MORC2 in cancer development and beyond

Review article | 更新时间：2024-02-04

- Oncogenic MORC2 in cancer development and beyond
- Genes & Diseases Vol. 11, Issue 2, (2024)
- 作者机构：
  
  1. Key Laboratory of Cell Biology, Department of Cell Biology, Ministry of Public Health and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University,Liaoning,Shenyang,China,110122
  2. Department of Breast Surgery, The First Affiliated Hospital of China Medical University,Liaoning,Shenyang,China,110001
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2023.05.010
  CLC：
- Published：2024，
  
  Published Online：1 March 2024，
扫描看全文
Shan Zhang, Ayao Guo, Huan Wang, et al. Oncogenic MORC2 in cancer development and beyond. [J]. Genes & Diseases 11(2).(2024)
DOI：

Shan Zhang, Ayao Guo, Huan Wang, et al. Oncogenic MORC2 in cancer development and beyond. [J]. Genes & Diseases 11(2).(2024) DOI： 10.1016/j.gendis.2023.05.010.

摘要

Abstract

Microrchidia CW-type zinc finger 2 (MORC2) is a member of the MORC superfamily of nuclear proteins. Growing evidence has shown that MORC2 not only participates in gene transcription and chromatin remodeling but also plays a key in human disease and tumor development by regulating the expression of downstream oncogenes or tumor suppressors. The present review provides an updated overview of MORC2 in the aspect of cancer hallmark and therapeutic resistance and summarizes its upstream regulators and downstream target genes. This systematic review may provide a favorable theoretical basis for emerging players of MORC2 in tumor development and new insight into the potential clinical application of basic science discoveries in the future.

关键词

Keywords

Cancer developmentHallmarks of cancerMORC2Therapeutic targetTreatment resistance

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

The Wnt-dependent and Wnt-independent functions of BCL9 in development, tumorigenesis, and immunity: Implications in therapeutic opportunities

Recent advances of mechanosensitive genes in vascular endothelial cells for the formation and treatment of atherosclerosis

Mechanistic insight into lysyl oxidase in vascular remodeling and angiogenesis

The SUMO E3 ligase CBX4 is identified as a poor prognostic marker of gastric cancer through multipronged OMIC analyses

Related Author

Minjie Wu

Heng Dong

Chao Xu

Mengqing Sun

Haojin Gao

Fangtian Bu

Jianxiang Chen

Guixue Wang

Related Institution

College of Pharmacy and Department of Hepatology, Institute of Hepatology and Metabolic Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University

Laboratory of Cancer Genomics, Division of Cellular and Molecular Research, National Cancer Centre

Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University

Key Laboratory of Biorheological Science and Technology of Ministry of Education, National and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University

Department of Neurosurgery, Daping Hospital, Army Medical Center of PLA, Army Medical University

⁰